Insider Transactions in Q4 2020 at Meridian Bioscience Inc (VIVO)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2020
|
Anthony P Bihl Iii Director |
BUY
Open market or private purchase
|
Direct |
5,000
+31.54%
|
$85,000
$17.65 P/Share
|
|
Nov 23
2020
|
Lourdes Weltzien Executive VP, Life Science |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-0.2%
|
$2,983
$19.08 P/Share
|
|
Nov 17
2020
|
David Phillips Director |
BUY
Bona fide gift
|
Direct |
796
+1.52%
|
-
|
|
Nov 17
2020
|
David Phillips Director |
SELL
Bona fide gift
|
Direct |
796
-12.07%
|
-
|
|
Nov 16
2020
|
Bryan T Baldasare Exec VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,991
-3.13%
|
$33,847
$17.11 P/Share
|
|
Nov 16
2020
|
Lourdes Weltzien Executive VP, Life Science |
SELL
Payment of exercise price or tax liability
|
Direct |
2,509
-3.15%
|
$42,653
$17.11 P/Share
|
|
Nov 05
2020
|
Bryan T Baldasare Exec VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,823
+14.54%
|
-
|
|
Nov 05
2020
|
John P. Kenny Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,006
+15.99%
|
-
|
|
Nov 05
2020
|
Tony Serafini Lamanna Executive VP-Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
10,823
+25.37%
|
-
|
|
Nov 05
2020
|
Lourdes Weltzien Executive VP, Life Science |
BUY
Grant, award, or other acquisition
|
Direct |
12,175
+13.25%
|
-
|